Total Debt

$1.99B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Total Debt

Latest reported$1.99Bperiod endingJun 30, 2026

REGN Quarterly Total Debt ($0.00 → $1.99B)

Quarterly total debt

High-resolution chart · PNG

REGN total debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Debt — Quarterly (USD)
Period ending	Total Debt (USD)
Jun 30, 2026	1,986,600,000
Mar 31, 2026	2,706,200,000
Dec 31, 2025	2,705,900,000
Sep 30, 2025	2,705,500,000
Jun 30, 2025	2,705,100,000
Mar 31, 2025	2,704,800,000
Dec 31, 2024	2,704,400,000
Sep 30, 2024	2,704,000,000
Jun 30, 2024	2,703,600,000
Mar 31, 2024	2,703,300,000
Dec 31, 2023	2,702,900,000
Sep 30, 2023	2,702,600,000
Jun 30, 2023	2,702,200,000
Mar 31, 2023	2,701,800,000
Dec 31, 2022	2,701,400,000
Sep 30, 2022	2,701,100,000
Jun 30, 2022	2,700,700,000
Mar 31, 2022	2,700,400,000
Dec 31, 2021	2,699,700,000
Sep 30, 2021	2,698,600,000
Jun 30, 2021	2,697,600,000
Mar 31, 2021	2,696,700,000
Dec 31, 2020	2,695,700,000
Sep 30, 2020	2,694,800,000
Jun 30, 2020	2,215,900,000
Mar 31, 2020	715,200,000
Dec 31, 2019	713,900,000
Sep 30, 2019	712,700,000
Jun 30, 2019	711,300,000
Mar 31, 2019	709,900,000
Dec 31, 2018	708,500,000
Sep 30, 2018	707,203,000
Jun 30, 2018	705,903,000
Mar 31, 2018	704,645,000
Dec 31, 2017	703,453,000
Sep 30, 2017	702,317,000
Jun 30, 2017	701,173,000
Mar 31, 2017	707,607,000
Dec 31, 2016	481,126,000
Sep 30, 2016	382,228,000
Jun 30, 2016	361,523,000
Mar 31, 2016	362,230,000
Dec 31, 2015	375,510,000
Sep 30, 2015	394,867,000
Jun 30, 2015	388,047,000
Mar 31, 2015	472,476,000
Dec 31, 2014	459,064,000
Sep 30, 2014	565,314,000
Jun 30, 2014	517,846,000
Mar 31, 2014	531,113,000
Dec 31, 2013	505,512,000
Sep 30, 2013	482,175,000
Jun 30, 2013	473,302,000
Mar 31, 2013	462,748,000
Dec 31, 2012	457,328,000
Sep 30, 2012	451,735,000
Jun 30, 2012	446,232,000
Mar 31, 2012	440,833,000
Dec 31, 2011	435,533,000
Sep 30, 2011	160,402,000
Jun 30, 2011	160,334,000
Mar 31, 2011	160,151,000
Dec 31, 2010	160,030,000
Sep 30, 2010	159,016,000
Jun 30, 2010	157,807,000
Mar 31, 2010	156,899,000
Dec 31, 2009	109,022,000
Sep 30, 2009	62,571,000
Jun 30, 2009	62,925,000
Mar 31, 2009	0
Dec 31, 2008	5,093,000
Sep 30, 2008	117,503,000
Jun 30, 2008	118,653,000
Mar 31, 2008	200,000,000
Dec 31, 2007	202,292,000
Sep 30, 2007	200,000,000
Jun 30, 2007	200,000,000
Mar 31, 2007	200,000,000
Dec 31, 2006	200,000,000
Sep 30, 2006	200,000,000
Jun 30, 2006	200,000,000
Mar 31, 2006	200,000,000
Dec 31, 2005	200,000,000
Sep 30, 2005	200,000,000
Jun 30, 2005	200,000,000
Mar 31, 2005	200,000,000
Dec 31, 2004	200,000,000
Sep 30, 2004	200,000,000
Jun 30, 2004	200,000,000
Mar 31, 2004	200,000,000
Dec 31, 2003	213,817,000
Sep 30, 2003	209,296,000
Jun 30, 2003	205,147,000
Mar 31, 2003	200,061,000
Dec 31, 2002	200,150,000
Sep 30, 2002	200,237,000
Jun 30, 2002	200,324,000
Mar 31, 2002	200,465,000
Dec 31, 2001	200,576,000
Sep 30, 2001	2,169,000